Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03259867 |
Title | Combination of TATE and PD-1 Inhibitor in Liver Cancer |
Acronym | TATE-PD1 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Teclison Ltd. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |